Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma

NCT07322965 is registered in ClinicalTrials.gov with Institut Catala de Retina as lead sponsor.

NCT NCT07322965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07322965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma
Lead sponsor
Institut Catala de Retina
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2025
Completion date
May 30, 2027
Enrollment
108 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, neuroprotection, primary open angle glaucoma (poag)